Cash Flow - Kymera Therapeutics, Inc. (KYMR)
$(Billion, Million)| Dec-25 | Dec-24 | Dec-23 | Dec-22 | Dec-21 | Dec-20 | Dec-19 | Dec-18 | |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | -232.89 | -194.50 | -102.83 | -153.09 | -128.95 | 88.13 | 17.91 | -17.86 |
| Cash flow from investing | -521.06 | -404.08 | 139.89 | 20.52 | -99.84 | -422.59 | -16.49 | -1.36 |
| Cash flow from financing | 990.71 | 608.85 | 4.19 | 153.00 | 250.28 | 289.26 | 34.91 | 52.93 |
| Change in cash | 236.76 | 10.27 | 41.25 | 20.43 | 21.50 | -45.20 | 36.33 | 33.71 |
Show Quarterly Cash Flow
Cash Flow - Kymera Therapeutics, Inc. (KYMR)
$(Billion, Million)| Mar-26 | Dec-25 | Sep-25 | Jun-25 | Mar-25 | Dec-24 | Sep-24 | Jun-24 | Mar-24 | Dec-23 | Sep-23 | Jun-23 | Mar-23 | Dec-22 | Sep-22 | Jun-22 | Mar-22 | Dec-21 | Sep-21 | Jun-21 | Mar-21 | Dec-20 | Sep-20 | Jun-20 | Mar-20 | Dec-19 | Sep-19 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | -88.84 | -66.75 | -27.11 | -59.88 | -79.15 | -61.78 | -50.19 | -42.94 | -39.59 | 8.05 | -31.65 | -35.26 | -43.97 | -39.54 | -34.27 | -38.99 | -40.30 | -38.35 | -37.26 | -30.51 | -22.82 | -20.07 | 131.67 | -11.41 | -12.06 | -10.80 | -12.47 |
| Cash flow from investing | -142.84 | -394.40 | -235.30 | 60.02 | 48.62 | 68.57 | -157.68 | 15.64 | -330.61 | 18.95 | 60.51 | 35.84 | 24.58 | -49.67 | -37.48 | 81.80 | 25.86 | -68.02 | -136.86 | 60.72 | 44.32 | -3.99 | -334.32 | -46.87 | -37.40 | 61.96 | -78.32 |
| Cash flow from financing | 18.77 | 705.22 | 39.51 | 245.73 | 0.26 | 2.77 | 250.92 | 1.41 | 353.76 | 1.93 | -0.21 | 1.31 | 1.16 | 1.95 | 150.50 | 0.36 | 0.19 | 2.05 | 246.04 | 1.59 | 0.60 | 0.27 | 196.28 | -0.40 | 93.12 | 21.09 | -0.04 |
| Change in cash | -212.91 | 244.07 | -222.90 | 245.86 | -30.28 | 9.55 | 43.05 | -25.88 | -16.44 | 28.93 | 28.66 | 1.89 | -18.23 | -87.25 | 78.75 | 43.18 | -14.25 | -104.32 | 71.92 | 31.80 | 22.10 | -23.79 | -6.38 | -58.69 | 43.66 | 72.25 | -90.84 |